Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Intervention in Children and Adolescents with Obesity
2024-517787-29-00Phase 2Completed
- Sponsor
- Region Uppsala
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in obesity (3 arms), sponsored by Region Uppsala. Primary endpoint: BMI-SDS (according to WHO). Started Oct 2024; status: completed.
02
Drugs
metformin
03
Conditions
obesity
Beyond the preview
Go deeper on 2024-517787-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517787-29-00.